Jun
2026
Shanghai New International Expo Center
Visit us
stand E1.1B07, Contract Services

Bioworkshops

Exhibitor at CPHI & PMEC China 2026
About Us

Bioworkshops is a China-based, science-driven biologics company specializing in biosimilar development and manufacturing. We focus on high-value, high-demand targets across a broad range of therapeutic areas, with over 66 biosimilar molecules developed spanning different stages from early research to commercial readiness. With extensive hands-on experience, we support global biosimilar development and registration, including 10+ NDA/BLA filings across multiple regions. Our team delivers end-to-end capabilities, including: • Cell line development (CLD) • Process development (upstream & downstream) • Analytical development & comparability studies • CMC development and documen...

Read more Show less
Products
Show more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    China
  • On CPHI since:
    2022
  • Certificates:
    1
  • Employees:
    100 - 249
Company types
CMO/CDMO
Start-up
Primary activities
Biopharmaceutical
View company profile
Contact info
  • +86-15618259078
  • No. 5, Dongwang Road,, Suzhou Industrial Park, Suzhou, China
Show contact info Hide contact info
Event information
CPHI & PMEC China 2026
  • 16 Jun 2026 - 18 Jun 2026
  • Shanghai New International Expo Center
  • Visit us at stand E1.1B07, Contract Services

Products Featured at CPHI & PMEC China 2026

  • Adalimumab

    Product Adalimumab

    Regulatory compliance: Developed from a cell line with DMF filing, ensuring global regulatory readiness and streamlined submissions.

    High titer: Optimized cell line and process deliver consistently strong productivity, supporting cost-efficient large-scale manufacturing.

    High degree o...
  • Anifrolumab

    Product Anifrolumab

    Regulatory compliance: Developed from a cell line with DMF filing, ensuring global regulatory readiness and streamlined submissions.

    High titer: Optimized cell line and process deliver consistently strong productivity, supporting cost-efficient large-scale manufacturing.

    High degree o...
  • Atezolizumab

    Product Atezolizumab

    Regulatory compliance: Developed from a cell line with DMF filing, ensuring global regulatory readiness and streamlined submissions.

    High titer: Optimized cell line and process deliver consistently strong productivity, supporting cost-efficient large-scale manufacturing.

    High degree o...
  • Bamlanivimab

    Product Bamlanivimab

    Regulatory compliance: Developed from a cell line with DMF filing, ensuring global regulatory readiness and streamlined submissions.

    High titer: Optimized cell line and process deliver consistently strong productivity, supporting cost-efficient large-scale manufacturing.

    High degree o...
  • Bebtelovimab

    Product Bebtelovimab

    Target: SARS-CoV-2 S protein CAS: 2578319-11-4

Bioworkshops Resources (1)